1.
Multitargeted therapy of cancer by green tea polyphenols
by Khan, Naghma
Cancer letters, 2008, Vol.269 (2), p.269-280

2.
Polyphenols: Planting the seeds of treatment for the metabolic syndrome
by Cherniack, E. Paul, M.D
Nutrition (Burbank, Los Angeles County, Calif.), 2011, Vol.27 (6), p.617-623

3.
Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial
by Schwartz, Sherwyn
Current medical research and opinion, 2011, Vol.27 (1), p.151-162

4.
Inhibition of carcinogenesis by dietary polyphenolic compounds
by YANG, Chung S
Annual review of nutrition, 2001, Vol.21 (1), p.381-406

5.
Mechanisms of combined action of different chemopreventive dietary compounds: a review
by de Kok, T.M
European journal of nutrition, 2008, Vol.47 (Suppl 2), p.51-9

6.
Synergism of three-drug combinations of sanguinarine and other plant secondary metabolites with digitonin and doxorubicin in multi-drug resistant cancer cells
by Eid, Safaa Yehia
Phytomedicine (Stuttgart), 2012, Vol.19 (14), p.1288-1297

7.
Green tea polyphenols for prostate cancer chemoprevention: A translational perspective
by Johnson, J.J
Phytomedicine (Stuttgart), 2010, Vol.17 (1), p.3-13

8.
Gastrodia elata and epilepsy: Rationale and therapeutic potential
by Matias, Mariana
Phytomedicine (Stuttgart), 2016, Vol.23 (12), p.1511-1526

9.
EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment
by Chen, Di
Advances in Clinical Chemistry, 2011, Vol.53, p.155-177

10.
Glabridin induces apoptosis and autophagy through JNK1/2 pathway in human hepatoma cells
by Hsieh, Ming-Ju
Phytomedicine (Stuttgart), 2016, Vol.23 (4), p.359-366

11.
A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain
by Daniels, Stephen E
Current medical research and opinion, 2009, Vol.25 (3), p.765-776

12.
Practical Considerations for the Use of Tapentadol Prolonged Release for the Management of Severe Chronic Pain
by Sánchez del Águila, Manuel J., FCARCSI
Clinical therapeutics, 2015, Vol.37 (1), p.94-113

13.
Influence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells
by Eid, Safaa Yehia
Phytomedicine (Stuttgart), 2013, Vol.21 (1), p.47-61

14.
Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: A...
by Hartrick, Craig, MD
Clinical therapeutics, 2009, Vol.31 (2), p.260-271

15.
Novel phytonutrient contributors to antioxidant protection against cardiovascular disease
by Riccioni, Graziano, M.D., Ph.D
Nutrition (Burbank, Los Angeles County, Calif.), 2012, Vol.28 (6), p.605-610

16.
A Thyroid Hormone-Based Strategy for Correcting the Biochemical Abnormality in X-Linked Adrenoleukodystrophy
by Hartley, Meredith D
Endocrinology (Philadelphia), 2017, Vol.158 (5), p.1328-1338

17.
Effects of grape antioxidant dietary fiber in cardiovascular disease risk factors
by Jiménez, Jara Pérez, Ph.D
Nutrition (Burbank, Los Angeles County, Calif.), 2008, Vol.24 (7), p.646-653

18.
Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extens...
by Buynak, Robert, MD
Clinical therapeutics, 2015, Vol.37 (11), p.2420-2438

19.
Antigenotoxicity, Cytotoxicity, and Apoptosis Induction by Apigenin, Bisabolol, and Protocatechuic Acid
by Anter, Jaouad
Journal of Medicinal Food, 14(3), pp.276-283

20.
Effects of Consumption of Pomegranate Juice on Carotid Intima–Media Thickness in Men and Women at Moderate Risk for Coronary Heart Disease
by Davidson, Michael H., MD
The American journal of cardiology, 2009, Vol.104 (7), p.936-942
